Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis
Authors
Keywords
-
Journal
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-04
DOI
10.1007/s12016-020-08796-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology
- (2019) Claudio Derada Troletti et al. Cell Death & Disease
- Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis
- (2019) Yan Zhang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Resolvins: Emerging Players in Autoimmune and Inflammatory Diseases
- (2019) Fereshte Abdolmaleki et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress
- (2019) Alessandro Leuti et al. Oxidative Medicine and Cellular Longevity
- Lipoxin-Induced Phenotypic Changes in CD115+LY6Chi Monocytes TAM Precursors Inhibits Tumor Development
- (2019) Natália Mesquita de-Brito et al. Frontiers in Oncology
- Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases
- (2019) Pei Shang et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction
- (2019) Gijs Kooij et al. HAEMATOLOGICA
- Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions
- (2019) Nan Chiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Resolution of inflammation during multiple sclerosis
- (2019) F. Ruiz et al. Seminars in Immunopathology
- Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
- (2019) Paraskevi Krashia et al. Nature Communications
- The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
- (2018) Joana Machado-Santos et al. BRAIN
- ERV1/ChemR23 Signaling Protects from Atherosclerosis by Modifying oxLDL Uptake and Phagocytosis in Macrophages
- (2018) Andres Laguna-Fernandez et al. CIRCULATION
- GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain
- (2018) Sangsu Bang et al. JOURNAL OF CLINICAL INVESTIGATION
- Key roles for lipid mediators in the adaptive immune response
- (2018) Parker F. Duffney et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
- (2018) Kjetil Bjornevik et al. Multiple Sclerosis Journal
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Course of Multiple Sclerosis
- (2018) Sylvia Klineova et al. Cold Spring Harbor Perspectives in Medicine
- α-Linolenic acid is associated with MRI activity in a prospective cohort of multiple sclerosis patients
- (2018) Kjetil Bjornevik et al. Multiple Sclerosis Journal
- Resolvin E1 Promotes Bone Preservation Under Inflammatory Conditions
- (2018) Karim El Kholy et al. Frontiers in Immunology
- Bioactive Lipids and Chronic Inflammation: Managing the Fire Within
- (2018) Valerio Chiurchiù et al. Frontiers in Immunology
- Maresin 1 attenuates neuroinflammation in a mouse model of perioperative neurocognitive disorders
- (2018) T. Yang et al. BRITISH JOURNAL OF ANAESTHESIA
- Resolution of inflammation in neuromyelitis optica spectrum disorders
- (2018) Xu Wang et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis risk factors contribute to onset heterogeneity
- (2018) Farren B.S. Briggs et al. Multiple Sclerosis and Related Disorders
- Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling
- (2017) Bochra Tourki et al. FASEB JOURNAL
- The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia-induced endoplasmic reticulum stress
- (2017) Bibiana Rius et al. FASEB JOURNAL
- Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms
- (2017) Charles N. Serhan FASEB JOURNAL
- Actions of SPM in regulating host responses in arthritis
- (2017) Mauro Perretti et al. MOLECULAR ASPECTS OF MEDICINE
- Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology
- (2017) Charles N. Serhan MOLECULAR ASPECTS OF MEDICINE
- Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors
- (2017) Nan Chiang et al. MOLECULAR ASPECTS OF MEDICINE
- Polyunsaturated fatty acids and the risk of multiple sclerosis
- (2017) Kjetil Bjørnevik et al. Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Polyunsaturated fatty acids and the risk of multiple sclerosis
- (2017) Kjetil Bjørnevik et al. Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats
- (2017) Beatrice Oehler et al. Frontiers in Molecular Neuroscience
- Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
- (2017) Jesmond Dalli et al. Frontiers in Immunology
- Protectin DX increases survival in a mouse model of sepsis by ameliorating inflammation and modulating macrophage phenotype
- (2017) Haifa Xia et al. Scientific Reports
- Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
- (2016) Joana Viola et al. CIRCULATION RESEARCH
- EPA- and DHA-derived resolvins' actions in inflammatory bowel disease
- (2016) Raquel Cristina Schwanke et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
- (2016) Melody G. Duvall et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study
- (2016) Paolo Riccio et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue
- (2016) Esther Titos et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 Programs Inflammation Resolution by Increasing TGF- Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis
- (2016) B. Luo et al. JOURNAL OF NEUROSCIENCE
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses
- (2016) Valerio Chiurchiù et al. Science Translational Medicine
- An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
- (2016) Gabrielle Fredman et al. Nature Communications
- Resolvin D1 Reduces Emphysema and Chronic Inflammation
- (2015) Hsi-Min Hsiao et al. AMERICAN JOURNAL OF PATHOLOGY
- Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome
- (2015) Charles N. Serhan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Disease-modifying treatments for multiple sclerosis - a review of approved medications
- (2015) Ø. Torkildsen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways
- (2015) Jesmond Dalli et al. FASEB JOURNAL
- Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis
- (2015) Laila M. Poisson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
- (2015) Marianna Cortese et al. Multiple Sclerosis Journal
- Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
- (2015) Jesmond Dalli et al. NATURE MEDICINE
- Specialised lipid mediators and their targets
- (2015) Daniel Crean et al. SEMINARS IN IMMUNOLOGY
- MARESIN 1 PREVENTS LIPOPOLYSACCHARIDE-INDUCED NEUTROPHIL SURVIVAL AND ACCELERATES RESOLUTION OF ACUTE LUNG INJURY
- (2015) Jie Gong et al. SHOCK
- Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
- (2015) Marianna Cortese et al. Multiple Sclerosis Journal
- Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes
- (2014) Song Hong et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Novel Targets in Multiple Sclerosis: To Oxidative Stress and Beyond
- (2014) Valerio Chiurchiu CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Resolvins RvD1 and 17(R)-RvD1 alleviate signs of inflammation in a rat model of endometriosis
- (2014) Natalia Dmitrieva et al. FERTILITY AND STERILITY
- Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
- (2014) Christopher D. Buckley et al. IMMUNITY
- Functional Analysis via Standardized Whole-Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli
- (2014) Darragh Duffy et al. IMMUNITY
- The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review
- (2014) Dimitrios Karussis JOURNAL OF AUTOIMMUNITY
- Resolvin D1 Stimulates Alveolar Fluid Clearance through Alveolar Epithelial Sodium Channel, Na,K-ATPase via ALX/cAMP/PI3K Pathway in Lipopolysaccharide-Induced Acute Lung Injury
- (2014) Q. Wang et al. JOURNAL OF IMMUNOLOGY
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
- (2014) P. Browne et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Lipoxin A4 Prevents the Progression of De Novo and Established Endometriosis in a Mouse Model by Attenuating Prostaglandin E2 Production and Estrogen Signaling
- (2014) Rajesh Kumar et al. PLoS One
- Lipid Mediators in the Resolution of Inflammation
- (2014) Charles N. Serhan et al. Cold Spring Harbor Perspectives in Biology
- Plasticity of Leukocytic Exudates in Resolving Acute Inflammation Is Regulated by MicroRNA and Proresolving Mediators
- (2013) Yongsheng Li et al. IMMUNITY
- Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis
- (2013) George A. Jelinek et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Maresin 1, a Proresolving Lipid Mediator Derived from Omega-3 Polyunsaturated Fatty Acids, Exerts Protective Actions in Murine Models of Colitis
- (2013) R. Marcon et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway
- (2013) Wang Yaxin et al. JOURNAL OF SURGICAL RESEARCH
- Pathology and disease mechanisms in different stages of multiple sclerosis
- (2013) Hans Lassmann JOURNAL OF THE NEUROLOGICAL SCIENCES
- Fatty fish intake is associated with decreased occurrence of multiple sclerosis
- (2013) Maria Bäärnhielm et al. Multiple Sclerosis Journal
- Efficacy of Fish Oil on Serum of TNFα, IL-1β, and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b
- (2013) V. Ramirez-Ramirez et al. Oxidative Medicine and Cellular Longevity
- Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial
- (2013) Harald Prüss et al. PLoS One
- Novel n-3 Immunoresolvents: Structures and Actions
- (2013) Jesmond Dalli et al. Scientific Reports
- Polyunsaturated fatty acids in multiple sclerosis therapy
- (2012) S. Wergeland et al. ACTA NEUROLOGICA SCANDINAVICA
- Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
- (2012) Sriram Krishnamoorthy et al. AMERICAN JOURNAL OF PATHOLOGY
- New and emerging disease modifying therapies for multiple sclerosis
- (2012) Shiv Saidha et al. Annals of the New York Academy of Sciences
- ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study)
- (2012) Øivind Torkildsen et al. ARCHIVES OF NEUROLOGY
- Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
- (2012) Charles N. Serhan et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
- (2012) Charles N. Serhan et al. FASEB JOURNAL
- Multiple sclerosis
- (2012) Alyssa Nylander et al. JOURNAL OF CLINICAL INVESTIGATION
- Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat
- (2012) J. Claria et al. JOURNAL OF IMMUNOLOGY
- Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
- (2012) A. P. Rogerio et al. JOURNAL OF IMMUNOLOGY
- Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury
- (2012) O Eickmeier et al. Mucosal Immunology
- Self-Limited versus Delayed Resolution of Acute Inflammation: Temporal Regulation of Pro-Resolving Mediators and MicroRNA
- (2012) Gabrielle Fredman et al. Scientific Reports
- Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
- (2011) Gabrielle Fredman et al. BIOCHEMICAL JOURNAL
- Metabolic Connections during Apoptotic Cell Engulfment
- (2011) Claudia Z. Han et al. CELL
- Complementary and alternative medicine for the treatment of multiple sclerosis
- (2011) Vijayshree Yadav et al. Expert Review of Clinical Immunology
- Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice
- (2011) Jason Hellmann et al. FASEB JOURNAL
- The resolution of inflammation: the devil in the flask and in the details
- (2011) Charles N. Serhan FASEB JOURNAL
- Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice
- (2011) A. F. Bento et al. JOURNAL OF IMMUNOLOGY
- Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis
- (2010) S. Nightingale et al. ACTA NEUROLOGICA SCANDINAVICA
- Nonresolving Inflammation
- (2010) Carl Nathan et al. CELL
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rare infections mimicking MS
- (2010) Vesna V. Brinar et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
- (2010) Antonio Recchiuti et al. FASEB JOURNAL
- Current Views on the Roles of Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis
- (2010) Mohamed El-behi et al. Journal of Neuroimmune Pharmacology
- The changing demographic pattern of multiple sclerosis epidemiology
- (2010) Nils Koch-Henriksen et al. LANCET NEUROLOGY
- Multiple sclerosis genetics—is the glass half full, or half empty?
- (2010) Jorge R. Oksenberg et al. Nature Reviews Neurology
- Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
- (2010) Ranjan Dutta et al. PROGRESS IN NEUROBIOLOGY
- Resolvins and protectins: mediating solutions to inflammation
- (2009) Payal Kohli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Resolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
- (2009) Taisuke Ohira et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A review of complementary and alternative medicine (CAM) by people with multiple sclerosis
- (2009) Sherri A. Olsen Occupational Therapy International
- Adding fuel to fire: microRNAs as a new class of mediators of inflammation
- (2008) F J Sheedy et al. ANNALS OF THE RHEUMATIC DISEASES
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
- Clinically isolated syndrome: the rationale for early treatment
- (2008) Giancarlo Comi Nature clinical practice. Neurology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now